Clinical trial · Observational
The Effect of Radioactive Iodine Administration for Thyroid Diseases on H.Pylori Eradication
Effect of Radioactive Iodine on Eradication of Helicobacter Pylori in Patients Treated for Thyroid Diseases
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Because of the high iodine uptake in the stomach, radioactive iodine treatment for thyroid diseases (cancer or hyperthyroidism) or radioactive iodine administered for thyroid scan may be able to eradicate H.pylori infection from the stomach of patients infected with H.pylori. Also to test the hypothesis that CagA virulent strains of H.pylori are more common in patients with thyroid cancer than with other thyroid diseases.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Helicobacter Pylori Infected Patients | — | UNRESOLVED | — |
| Hyperthyroidism | — | UNRESOLVED | — |
| Thyroid Cancer Patients | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 85 Years
Show eligibility criteria text
Inclusion Criteria: * Adult patients between the ages of 18 and 80. * Patients with diagnosed thyroid disease referred for thyroid scan or treatment with radioactive iodine (131I). * Patients who provide informed consent Exclusion Criteria: * Patients without diagnosed thyroid disease. * Patients who are pregnant or breast feeding. * Patients who have received previous treatment for H. pylori infection. * Patients taking proton pump inhibitors. * Patients with recent or current use of antibiotics. * Patients allergic to iodine (131I).
References
Publications (0)
Data not yet available